Observational Study on the Safety and Efficacy of the Medical Product Fructosin.
Not yet recruiting
- Conditions
- Fructose Intolerance
- Interventions
- Device: Fructosin
- First Posted Date
- 2023-09-21
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Sciotec Diagnostic Technologies GmbH
- Target Recruit Count
- 60
- Registration Number
- NCT06044389
- Locations
- 🇦🇹
Sciotec Diagnostic Technologies GmbH, Tulln, Niederösterreich, Austria
Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity
Not Applicable
Completed
- Conditions
- Histamine IntoleranceFood Intolerance
- Interventions
- Dietary Supplement: DAOsin
- First Posted Date
- 2017-10-02
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Sciotec Diagnostic Technologies GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT03298568
- Locations
- 🇦🇹
Ordination für Innere Medizin und Stoffwechselzentrum, Bruck an der Mur, Austria
Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption
Not Applicable
Completed
- Conditions
- Fructose Malabsorption
- Interventions
- Dietary Supplement: Fructosin
- First Posted Date
- 2009-06-09
- Last Posted Date
- 2010-12-20
- Lead Sponsor
- Sciotec Diagnostic Technologies GmbH
- Target Recruit Count
- 65
- Registration Number
- NCT00916487
- Locations
- 🇦🇹
Medical University of Graz, Graz, Styria, Austria
© Copyright 2025. All Rights Reserved by MedPath